Nutritional factors and Alzheimer's disease

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 11, 2001, Pages

  Reynish, William ^a   Andrieu, Sandrine ^a   Nourhashemi, Fati ^a   Vellas, Bruno ^a  

^a Toulouse University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; FREE RADICAL;

ALZHEIMER DISEASE; BODY WEIGHT; COGNITION; COGNITIVE DEFECT; ENERGY METABOLISM; HUMAN; HYPERHOMOCYSTEINEMIA; LIPID DIET; NUTRITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCAVENGING SYSTEM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTICHOLESTEREMIC AGENTS; AVITAMINOSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET; DIETARY FATS; ENERGY METABOLISM; HUMANS; NUTRITION PHYSIOLOGY; NUTRITIONAL STATUS; OXIDATIVE STRESS; WEIGHT LOSS;

EID: 0034767383     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.11.M675     Document Type: Review

References (64)

1. Uber eine eigenartige erkrankung der hirnrinde
2. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
3. Weight loss in Alzheimer's disease: An international review of the literature
4. Weight loss in Alzheimer's disease
5. Weight loss in Alzheimer's disease: A longitudinal study
6. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects
7. Weight change in Alzheimer's disease
8. Weight loss in Alzheimer disease
9. Longitudinal weight changes, length of survival, and energy requirements of long-term care residents with dementia
10. Weight loss precedes dementia in community-dwelling older adults
11. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy
12. Is severe wasting in elderly mental patients caused by an excessive energy requirement?
13. Daily energy expenditure in free-living non-institutionalized Alzheimer's patients: A doubly labeled water study
14. Appendicular skeletal muscle mass, physical activity, and cognitive status in patients with Alzheimer's disease
15. Do nutrition indicators predict death in elderly Canadians with cognitive impairment?
16. The association of weight change in Alzheimer's disease with severity of disease and mortality: A longitudinal analysis
17. Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients
18. Relationships between nutritional markers and the mininutritional assessment in 155 older persons
19. Emerging neuroprotective strategies for Alzheimer's disease: Dietary restriction, telomerase activation, and stem cell therapy
20. Causes of weight loss in a community nursing home
21. B vitamins, homocysteine, and neurocognitive function in the elderly
22. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?
23. Clinical spectrum and diagnosis of cobalamin deficiency
24. Total serum homocysteine in senile dementia of Alzheimer type
25. Serum cobalamin and methylmalonic acid in Alzheimer dementia
26. Cobalamin levels are not reduced in Alzheimer's disease: Results from a population-based study
27. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
28. Serum folate the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study
29. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia
30. The role of cerebral ischemia in Alzheimer's disease
31. AACBCC. Immunohistochemical evidence for apoptosis in Alzheimer's disease
32. Apoptosis and Alzheimer's disease
33. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
34. Is there epidemiologic evidence that anti-oxidants protect against disorders in cognitive function?
35. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
36. Women, myocardial infarction, and dementia in the very old
37. Risk factors for vascular disease and dementia
38. The association between APOE and dementia does not seem to be mediated by vascular factors
39. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
40. ApoE genotype in relation to AD and cholesterol: A study of 2,326 Chinese adults
41. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans
42. Interaction of apolipoprotein E genotype, total cholesterol, and sex in prediction of Alzheimer's disease: A case control study
43. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels
44. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
45. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
46. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross-sectional population-based study
47. Dietary fat intake and the risk of incident dementia in the Rotterdam study
48. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men
49. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein
50. Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway
51. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
52. The role of cholesterol in the biosynthesis of beta-amyloid
53. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations
54. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
55. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory
56. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice
57. Changes in membrane fatty acids and delta-9 desaturase in senescence accelerated (SAMP8) mouse hippocampus with aging
58. Dietary alpha-linolenate linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM)
59. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
60. Statins and the risk of dementia
61. Dietary cholesterol induces Alzheimer-like beta-amyloid immunoreactivity in rabbit brain
62. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance
63. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia